Dr Rebecca Hood

Dr Rebecca Hood

Honorary Associate Lecturer

School of Biomedical Sciences and Pharmacy

Career Summary

Biography

As a Greaves Family post-graduate scholar, Rebecca's doctoral work focused on understanding the mechanisms underlying the pressure rise within the skull after ischaemic stroke (blockage of an artery in the brain). Since completing her PhD, her postdoctoral career is continuing in the stroke research field with Professor Rohan Walker and Professor Michael Nilsson. Here, her research is focused on post-stroke recovery. 


Qualifications

  • Doctor of Philosophy in Human Physiology, University of Newcastle
  • Bachelor of Biomedical Sciences, University of Newcastle
  • Bachelor of Biomedical Sciences (Hons), University of Newcastle

Keywords

  • Biomedical Sciences - Neuroscience
  • Cerebrospinal Fluid
  • Hypoxia
  • Intracranial Pressure
  • Ischaemic Stroke
  • Medical Physiology

Fields of Research

Code Description Percentage
320903 Central nervous system 75
320506 Medical biochemistry - proteins and peptides (incl. medical proteomics) 25

Professional Experience

Professional appointment

Dates Title Organisation / Department
1/8/2018 -  TACTICS VR Project Manager Faculty of Health and Medicine, The University of Newcastle
Australia
Edit

Publications

For publications that are currently unpublished or in-press, details are shown in italics.


Chapter (1 outputs)

Year Citation Altmetrics Link
2022 Ong L, Ilicic M, Hood R, Warren K, Coupland K, 'Targeting Adult Neurogenesis for Brain Recovery After Stroke: The Next Frontier in Stroke Medicine' (2022)
Citations Scopus - 1
Co-authors Marina Paul, Kirsten Coupland

Conference (20 outputs)

Year Citation Altmetrics Link
2024 Hood RJ, Cross CB, Stuckey SM, Costigan-Dwyer RA, Joubert SL, Walker M, Farr TD, Almuqbel M, Williams G, Wardill HR, Turner RJ, 'Thinking beyond the brain: Long-term changes in the gut-brain-axis post-stroke', CEREBROVASCULAR DISEASES, 53, 31-31 (2024)
2024 Paul M, Paul J, Hinwood M, Martin K, Hood R, Johnson S, Nilsson M, Walker R, 'Clopidogrel Administration Impairs Neurovascular Unit Recovery and Exacerbates Amyloid Beta Accumulation in Aged Mice Post-Stroke' (2024)
Co-authors Jonathan Paul, Michael Nilsson, Madeleine Hinwood, Rohan Walker, Marina Paul
2024 Paul M, Paul J, Hinwood M, Martin K, Hood R, Johnson S, Nilsson M, Walker R, 'Clopidogrel Administration Impairs Post-Stroke Learning and Memory Recovery in Mice' (2024)
Co-authors Jonathan Paul, Michael Nilsson, Madeleine Hinwood, Rohan Walker, Marina Paul
2023 Paul M, Paul JW, Hinwood M, Martin K, Hood R, Johnson S, Nilsson M, Walker F, 'Clopidogrel Inhibition of Microglial Chemotaxis Impairs Cognitive Recovery Post-Stroke' (2023)
Co-authors Jonathan Paul, Marina Paul, Madeleine Hinwood, Michael Nilsson, Rohan Walker
2023 Paul M, Paul J, Hinwood M, Martin K, Hood R, Johnson S, Nilsson PM, Walker F, 'Clopidogrel Administration Impairs Post-Stoke Learning and Memory Recovery in Mice' (2023)
Co-authors Jonathan Paul, Madeleine Hinwood, Rohan Walker, Michael Nilsson, Marina Paul
2023 Paul M, Paul J, Hinwood M, Martin K, Hood R, Johnson S, Nilsson PM, Walker F, 'Clopidogrel Administration Impairs Post-Stoke Learning and Memory Recovery in Mice' (2023)
Co-authors Michael Nilsson, Marina Paul, Rohan Walker, Madeleine Hinwood, Jonathan Paul
2022 Hood R, Persson M, Fhager A, Elam M, Karlsson J-E, Kurz M, Nilsson M, Lillicrap T, Esperon CG, Levi C, 'EVALUATING THE SENSITIVITY AND SPECIFICITY OF A MICROWAVE BASED TOOL TO SUPPORT AND ENHANCE STROKE TRIAGE', INTERNATIONAL JOURNAL OF STROKE, 17, 64-65 (2022)
Co-authors Michael Nilsson, Christopher Levi
2022 Maltby S, Hood R, Keynes A, Kluge M, Nalivaiko E, Ryan A, Cox M, Parsons M, Butcher K, Paul C, Garcia-Esperon C, Spratt N, Levi C, Walker F, 'Ongoing implementation of TACTICS VR: virtual reality-based acute stroke care workflow training', INTERNATIONAL JOURNAL OF STROKE, 17, 28-28 (2022)
Co-authors Carlos Garciaesperon, Christopher Levi, Neil Spratt, Steven Maltby, Rohan Walker, Chris Paul
2022 Warren K, Coupland K, Hood R, Kang L, Walker R, Spratt N, 'Cerebrospinal fluid circulation and outflow is reduced 24 hours but not 2 weeks after stroke', JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, Glasgow, SCOTLAND (2022)
Co-authors Neil Spratt
2022 Ilicic M, Paul J, Hinwood M, Martin K, Hood R, Johnson S, Nilsson M, Walker F, 'COGNITIVE IMPACTS OF ANTIPLATELETS USED FOR SECONDARY STROKE PREVENTION', INTERNATIONAL JOURNAL OF STROKE, 17, 205-205 (2022)
Co-authors Jonathan Paul, Madeleine Hinwood, Rohan Walker, Michael Nilsson, Marina Paul
2021 Hood RJ, Maltby S, Keynes A, Kluge MG, Nalivaiko E, Ryan AE, Cox M, Parsons MW, Butcher K, Paul CL, Garcia-Esperon C, Spratt NJ, Levi CR, Walker RF, 'Development and implementation of TACTICS VR: Virtual reality-based acute stroke care workflow training', INTERNATIONAL JOURNAL OF STROKE, 16, 27-27 (2021)
Co-authors Carlos Garciaesperon, Christopher Levi, Steven Maltby, Rohan Walker, Chris Paul, Neil Spratt
2021 Ilicic M, Paul JW, Hinwood M, Martin K, Hood RJ, Johnson SJ, Nilsson M, Walker R, 'Antiplatelet medications and cognitive function: Do we have something to be worried about?', INTERNATIONAL JOURNAL OF STROKE, 16, 14-14 (2021)
Co-authors Michael Nilsson, Marina Paul, Madeleine Hinwood, Jonathan Paul
2019 Zhao Z, Ong LK, Hood R, Pietrogrande G, Sanchez Bezanilla S, Warren K, Paul M, Kluge M, Tebay C, Ottersen O, Johnson S, Nilsson M, Walker F, 'Low Oxygen Post-Conditioning Improves Cognition and Reduces Amyloid Beta Accumulation Post-Stroke in Mice' (2019)
Co-authors Marina Paul, Rohan Walker, Michael Nilsson
2017 Warren KE, Beard DJ, Hood RJ, Spratt NJ, 'Intracranial pressure elevation is delayed following intracerebral hemorrhage in rats', JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, Int Soc Cerebral Blood Flow & Metab, Berlin, GERMANY (2017)
Co-authors Neil Spratt, Daniel J Beard
2017 Kovacs T, Murtha L, Beard D, McLeod D, Hood R, Garcia-Esperon C, Demeestere J, Levi C, Schmidt B, Spratt N, 'A potential cause of early neurological deterioration after mild-moderate ischaemic stroke - raised intracranial pressure at 24 hours', INTERNATIONAL JOURNAL OF STROKE, 12, 34-34 (2017)
Citations Web of Science - 1
Co-authors Neil Spratt, Damian Mcleod, Daniel J Beard, Lucy Murtha, Christopher Levi, Carlos Garciaesperon
2017 Hood RJ, McLeod DD, Warren KE, Pepperall D, Spratt NJ, 'Are there factors within cerebrospinal fluid that cause intracranial pressure to rise after subarachnoid hemorrhage?', JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, Int Soc Cerebral Blood Flow & Metab, Berlin, GERMANY (2017)
Co-authors Damian Mcleod, Neil Spratt
2016 McLeod DD, Murtha LA, Beard DJ, Hood RJ, Logan CL, Pepperall D, Spratt NJ, 'Elevated intracranial pressure following stroke: there's more to the story than cerebral oedema.', JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 36, 114-115 (2016)
Co-authors Neil Spratt, Damian Mcleod, Lucy Murtha, Daniel J Beard
2016 Murtha L, Hood R, Beard D, Pepperall D, McLeod D, Spratt N, 'DELAYED INTRACRANIAL PRESSURE ELEVATION FOLLOWING ISCHEMIC STROKE IS PREVENTED BY EARLY AND SHORT HYPOTHERMIA TREATMENT IN AGED RATS', JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, Vancouver, CANADA (2016)
Co-authors Neil Spratt, Daniel J Beard
2016 Beard DJ, Logan CL, McLeod DD, Hood RJ, Pepperall D, Murtha LA, Spratt NJ, 'MIDDLE CEREBRAL ARTERY OCCLUSION WITH GOOD COLLATERALS CAUSES EARLY INTRACRANIAL PRESSURE ELEVATION POST STROKE', JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 36, 442-443 (2016)
Co-authors Lucy Murtha, Daniel J Beard, Damian Mcleod, Neil Spratt
2016 Hood RJ, McLeod DD, Logan CL, Beard DJ, Li R, Spratt NJ, 'FACTOR(S) WITHIN CEREBROSPINAL FLUID POST-STROKE CAUSE INTRACRANIAL PRESSURE TO RISE IN HUMANS AND ANIMALS', JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, Vancouver, CANADA (2016)
Co-authors Daniel J Beard, Neil Spratt, Damian Mcleod
Show 17 more conferences

Journal article (24 outputs)

Year Citation Altmetrics Link
2025 Stuckey SM, Hood RJ, Ong LK, Bilecki IM, Collins-Praino LE, Turner RJ, 'Unravelling the nexus of stroke and dementia: Deciphering the role of secondary neurodegeneration in orchestrating cognitive decline', Neuroprotection (2025) [C1]

Stroke is the leading cause of acquired disability. The development of acute ischemic stroke treatments, such as mechanical thrombectomy and tissue plasminogen activato... [more]

Stroke is the leading cause of acquired disability. The development of acute ischemic stroke treatments, such as mechanical thrombectomy and tissue plasminogen activator, has resulted in more patients surviving the initial insult. However, long-term complications, such as post-stroke cognitive impairment (PSCI) and dementia (PSD), are at an all-time high. Notably, 80% of stroke survivors suffer from cognitive impairment, and a history of stroke doubles a patient's lifetime risk of developing dementia. A combination of greater life expectancy, an increase in the number of strokes in young individuals, and improved survival have inherently increased the number of years patients are living post-stroke, highlighting the critical need to understand the long-term effects of stroke, including how pathological changes in the brain might give rise to functional and behavioral changes in stroke survivors. Even with this increased risk of PSCI and PSD in stroke survivors, understanding of how the stroke itself develops into these conditions remains incomplete. Recently, secondary neurodegeneration (SND) following stroke has been linked with PSCI and PSD. SND is the degeneration of brain regions outside the original stroke site. Degeneration in these sites is thought to arise due to functional diaschisis with the infarct core; however, observation of SND pathology in multiple regions without direct connectivity to the stroke infarct suggests that the degeneration in these regions is likely more complex. Moreover, pathological hallmarks of dementia, such as a deposition of neurodegenerative proteins and iron, cell death, inflammation and blood¿brain barrier alterations, have all been found in regions such as the thalamus, hippocampus, basal ganglia, amygdala and prefrontal cortex following stroke. Hence, in this review, we present the current understanding of PSCI and PSD in the context of SND and outline how remote anatomical and molecular changes may drive the development of these conditions.

DOI 10.1002/nep3.74
2025 Litman M, Azarpeykan S, Hood RJ, Martin K, Pepperall D, Omileke D, Williams F, Uzun O, Bhatta D, Yong YK, Chan A, Hough N, Johnson S, Bermejo PG, Miteff F, Esperon CG, Couch Y, Buchan AM, Spratt NJ, Korin N, Ingber DE, Beard DJ, 'Shear Stress Targeted Delivery of Nitroglycerin to Brain Collaterals Improves Ischaemic Stroke Outcome', Advanced Science, 12 (2025) [C1]
DOI 10.1002/advs.202506276
Co-authors Sarah Johnson, Neil Spratt, Yuenkuan Yong, Daniel J Beard
2024 Woods AG, Lillicrap T, Hood R, Fletcher JW, Ranhage V, Larsson E, Cahlin F, Jood K, Tatlisumak T, Garcia-Esperon C, Spratt NJ, 'Blood pressure variability is associated with Infarct Growth in Acute Ischemic Stroke', CEREBROVASCULAR DISEASES, 53, 449-456 (2024) [C1]

Introduction: Evidence-based blood pressure (BP) targets in acute ischaemic stroke are lacking. Previous observational studies have focused on single baseline BP and cl... [more]

Introduction: Evidence-based blood pressure (BP) targets in acute ischaemic stroke are lacking. Previous observational studies have focused on single baseline BP and clinical outcomes, without consideration for dynamic changes. We aim to determine the association between BP parameters including variability, peak, nadir, median and mean during stroke and infarct growth (primary outcome), risk of haemorrhagic transformation, and functional outcome (secondary outcomes). Methods: Suspected stroke patients were prospectively recruited from a single comprehensive stroke centre. Multimodal computed tomography imaging was used to define infarct core. BP was recorded as per national stroke guidelines during the initial 24 h. Infarct growth and evidence of parenchymal haemorrhage were determined by follow-upmagnetic resonance imaging at 24 h. Functional outcome at 3 months was assessed using the modified Rankin Scale. Subgroup analysis was performed according to stroke aetiology and treatment for the association between BP, infarct volume growth, and risk of haemorrhagic transformation. The association between BP parameters and outcomes were determined using regression modelling. Results: A total of 229 patients were included in this study. Themedian agewas 67.4, 64.4%weremale, and the baseline National Institutes of Health Stroke Scale was 8. BP variability (BPV) was independently associated with increased infarct growth (multivariate coefficient 1.60, 95%CI: 0.27-2.94, p = 0.19) and an increased odds of parenchymal haemorrhage (adjusted OR 1.21, 95% CI: 1.02-1.44, p = 0.028). The odds of a favourable outcome at 90 days were inversely associated with BPV on simple, but not adjusted logistic regression. On subgroup analysis, only in patients with large vessel occlusions, undergoing endovascular clot retrieval, was BPV associated with infarct growth (multivariate-adjusted coefficient 2.62, 95% CI: 0.53-4.70, p = 0.014) and an increased odds of haemorrhagic transformation (adjusted OR 1.26, 95% CI: 1.01-1.57, p = 0.045). Conclusion: An increase in BPV was associated with infarct expansion, increased risk of haemorrhagic transformation and was negatively associated with favourable functional outcomes at 3 months.

DOI 10.1159/000533737
Citations Scopus - 7Web of Science - 1
Co-authors Carlos Garciaesperon, Neil Spratt
2024 Sorby-Adams AJ, Marian OC, Bilecki IM, Elms LE, Yassi N, Hood RJ, Coller JK, Stuckey SM, Kimberly WT, Farr TD, Leonard AV, Thornton E, Vink R, Turner RJ, 'NK1 tachykinin receptor antagonist treatment reduces cerebral edema and intracranial pressure in an ovine model of ischemic stroke', Journal of Cerebral Blood Flow and Metabolism, 44, 1759-1773 (2024) [C1]

Following ischemic stroke, substance P (SP)-mediated neurogenic inflammation is associated with profound blood-brain barrier (BBB) dysfunction, cerebral edema, and elev... [more]

Following ischemic stroke, substance P (SP)-mediated neurogenic inflammation is associated with profound blood-brain barrier (BBB) dysfunction, cerebral edema, and elevated intracranial pressure (ICP). SP elicits its effects by binding the neurokinin 1 tachykinin receptor (NK1-R), with administration of an NK1-R antagonist shown to ameliorate BBB dysfunction and cerebral edema in rodent and permanent ovine stroke models. Given the importance of reperfusion in clinical stroke, this study examined the efficacy of NK1-R antagonist treatment in reducing cerebral edema and ICP in an ovine model of transient middle cerebral artery occlusion (tMCAo). Anesthetized sheep (n = 24) were subject to 2-hours tMCAo and randomized (n = 6/group) to receive early NK1-R treatment (days 1¿3 post-stroke), delayed NK1-R treatment (day 5 post-stroke), or saline vehicle. At 6-days post-stroke animals were re-anaesthetized and ICP measured, followed by MRI to evaluate infarction, edema and BBB dysfunction. Following both early and delayed NK1-R antagonist administration, ICP was significantly reduced on day 6 compared to vehicle animals (p < 0.05), accompanied by a reduction in cerebral edema, midline shift and BBB dysfunction (p < 0.05). This study demonstrates that NK1-R antagonist treatment is an effective novel therapy for cerebral edema and elevated ICP following stroke in an ovine model, warranting future clinical evaluation.

DOI 10.1177/0271678X241241907
Citations Scopus - 2
2024 Warren KE, Hood RJ, Walker FR, Spratt NJ, 'Intracranial pressure is elevated at 24 h post-stroke in mice', Neuroprotection, 2, 60-64 (2024) [C1]

Background: It has long been assumed that post-stroke intracranial pressure (ICP) elevation occurs because of large infarct and edema volumes. However, we have repeated... [more]

Background: It has long been assumed that post-stroke intracranial pressure (ICP) elevation occurs because of large infarct and edema volumes. However, we have repeatedly shown ICP elevation at 24 h post-stroke in the presence of little to no edema in rats. Biological processes are often conserved across species and types of injury. Therefore, we aimed to determine if an ICP rise occurs at 24 h post-stroke in the presence of small infarct and edema volumes in mice. Methods: Mice were randomized by random number table to either photothrombotic stroke or sham surgery (n = 15). Epidural ICP was recorded using a fiber optic catheter at 1 h post-stroke (baseline) and between 23 and 24 h post-stroke. Results: ICP was significantly higher at 24 h compared to baseline in stroke animals (n = 6; 10.71 ± 6.45 mmHg vs. 3.74 ± 2.20 mmHg, respectively; p = 0.03). ICP at 24 h was also significantly higher in stroke mice compared to sham (n = 6; 3.45 ± 1.43 mmHg; p = 0.02). There was no change in ICP in sham mice (p = 0.9). Edema volumes in stroke animals were small (0.04 ± 0.04 mm3) and unlikely to have caused significant ICP elevation. Conclusion: This study provides¿evidence of an edema-independent ICP elevation following small ischemic stroke in mice. The occurrence of this rise supports our findings in other species and suggests it is caused by a previously undescribed mechanism.

DOI 10.1002/nep3.36
Co-authors Neil Spratt, Rohan Walker
2023 Hood RJ, Beard DJ, McLeod DD, Murtha LA, Spratt NJ, 'Intracranial pressure elevation post-stroke: Mechanisms and consequences', Frontiers in Stroke, 2 [C1]
DOI 10.3389/fstro.2023.1119120
Co-authors Daniel J Beard, Damian Mcleod, Lucy Murtha
2023 Hood RJ, Sanchez-Bezanilla S, Beard DJ, Rust R, Turner RJ, Stuckey SM, Collins-Praino LE, Walker FR, Nilsson M, Ong LK, 'Leakage beyond the primary lesion: A temporal analysis of cerebrovascular dysregulation at sites of hippocampal secondary neurodegeneration following cortical photothrombotic stroke', JOURNAL OF NEUROCHEMISTRY, 167, 733-752 (2023) [C1]

We have previously demonstrated that a cortical stroke causes persistent impairment of hippocampal-dependent cognitive tasks concomitant with secondary neurodegenerativ... [more]

We have previously demonstrated that a cortical stroke causes persistent impairment of hippocampal-dependent cognitive tasks concomitant with secondary neurodegenerative processes such as amyloid-ß accumulation in the hippocampus, a region remote from the primary infarct. Interestingly, there is emerging evidence suggesting that deposition of amyloid-ß around cerebral vessels may lead to cerebrovascular structural changes, neurovascular dysfunction, and disruption of blood¿brain barrier integrity. However, there is limited knowledge about the temporal changes of hippocampal cerebrovasculature after cortical stroke. In the current study, we aimed to characterise the spatiotemporal cerebrovascular changes after cortical stroke. This was done using the photothrombotic stroke model targeting the motor and somatosensory cortices of mice. Cerebrovascular morphology as well as the co-localisation of amyloid-ß with vasculature and blood¿brain barrier integrity were assessed in the cortex and hippocampal regions at 7, 28 and 84 days post-stroke. Our findings showed transient cerebrovascular remodelling in the peri-infarct area up to 28 days post-stroke. Importantly, the cerebrovascular changes were extended beyond the peri-infarct region to the ipsilateral hippocampus and were sustained out to 84 days post-stroke. When investigating vessel diameter, we showed a decrease at 84 days in the peri-infarct and CA1 regions that were exacerbated in vessels with amyloid-ß deposition. Lastly, we showed sustained vascular leakage in the peri-infarct and ipsilateral hippocampus, indicative of a compromised blood¿brain-barrier. Our findings indicate that hippocampal vasculature may represent an important therapeutic target to mitigate the progression of post-stroke cognitive impairment.

DOI 10.1111/jnc.16008
Citations Scopus - 3Web of Science - 1
Co-authors Michael Nilsson, Rohan Walker, Daniel J Beard
2023 Paul M, Paul J, Hinwood M, Hood R, Martin K, Abdolhoseini M, Johnson S, Pollack M, Nilsson PM, Walker F, 'Clopidogrel Administration Impairs Post-Stroke Learning and Memory Recovery in Mice', International Journal of Molecular Sciences (2023) [C1]
DOI 10.3390/ijms241411706
Citations Scopus - 1Web of Science - 4
Co-authors Rohan Walker, Michael Nilsson, Mahmoud Abdolhoseini, Sarah Johnson, Marina Paul, Jonathan Paul, Madeleine Hinwood
2023 Warren KE, Coupland KG, Hood RJ, Kang L, Walker FR, Spratt NJ, 'Movement of cerebrospinal fluid tracer into brain parenchyma and outflow to nasal mucosa is reduced at 24 h but not 2 weeks post-stroke in mice', FLUIDS AND BARRIERS OF THE CNS, 20 (2023) [C1]

Background: Recent data indicates that cerebrospinal fluid (CSF) dynamics are disturbed after stroke. Our lab has previously shown that intracranial pressure rises dram... [more]

Background: Recent data indicates that cerebrospinal fluid (CSF) dynamics are disturbed after stroke. Our lab has previously shown that intracranial pressure rises dramatically 24¿h after experimental stroke and that this reduces blood flow to ischaemic tissue. CSF outflow resistance is increased at this time point. We hypothesised that reduced transit of CSF through brain parenchyma and reduced outflow of CSF via the cribriform plate at 24¿h after stroke may contribute to the previously identified post-stroke intracranial pressure elevation. Methods: Using a photothrombotic permanent occlusion model of stroke in C57BL/6 adult male mice, we examined the movement of an intracisternally infused 0.5% Texas Red dextran throughout the brain and measured tracer efflux into the nasal mucosa via the cribriform plate at 24¿h or two weeks after stroke. Brain tissue and nasal mucosa were collected ex vivo and imaged using fluorescent microscopy to determine the change in CSF tracer intensity in these tissues. Results: At 24¿h after stroke, we found that CSF tracer load was significantly reduced in brain tissue from stroke animals in both the ipsilateral and contralateral hemispheres when compared to sham. CSF tracer load was also reduced in the lateral region of the ipsilateral hemisphere when compared to the contralateral hemisphere in stroke brains. In addition, we identified an 81% reduction in CSF tracer load in the nasal mucosa in stroke animals compared to sham. These alterations to the movement of CSF-borne tracer were not present at two weeks after stroke. Conclusions: Our data indicates that influx of CSF into the brain tissue and efflux via the cribriform plate are reduced 24¿h after stroke. This may contribute to reported increases in intracranial pressure at 24¿h after stroke and thus worsen stroke outcomes.

DOI 10.1186/s12987-023-00427-2
Citations Scopus - 5Web of Science - 2
Co-authors Rohan Walker, Neil Spratt, Kirsten Coupland
2023 Kuhne C, Kecelioglu ED, Maltby S, Hood RJ, Knott B, Ditton E, Walker FR, Kluge MG, 'Direct comparison of virtual reality and 2D delivery on sense of presence, emotional and physiological outcome measures', FRONTIERS IN VIRTUAL REALITY, 4 (2023) [C1]

Introduction: Virtual-reality (VR) technology has, over the last decade, quickly expanded from gaming into other sectors including training, education, and wellness. On... [more]

Introduction: Virtual-reality (VR) technology has, over the last decade, quickly expanded from gaming into other sectors including training, education, and wellness. One of the most popular justifications for the use of VR over 2D is increased immersion and engagement. However, very little fundamental research has been produced evaluating the comparative impact of immersive VR on the user's cognitive, physiological, and emotional state. Methods: A within-subject cross-over study design was used to directly compare VR and 2D screen delivery of different subject matter content. Both physiological and self-report data were collected for scenes containing calming nature environments, aggressive social confrontations, and neutral content. Results: Compared to 2D, the VR delivery resulted in a higher sense of presence, higher ratings of engagement, fun, and privacy. Confrontational scenes were rated as more tense whilst calming scenes were rated as more relaxing when presented in VR compared to 2D. Physiological data indicated that the scenes promoted overall states of arousal and relaxation in accordance with the scene subject matter (both VR and 2D). However, heart rate (HR) and galvanic skin response (GSR) were consistently higher throughout the VR delivery condition compared to 2D, including responses during scenes of neutral and calming subject matter. Discussion: This discrepancy between emotional and physiological responses for calming and neutral content in VR suggest an elevated arousal response driven by VR immersion that is independent of the emotional and physiological responses to the subject matter itself. These findings have important implications for those looking to develop and utilize VR technology as a training and educational tool as they provide insights into the impact of immersion on the user.

DOI 10.3389/frvir.2023.1211001
Citations Scopus - 2Web of Science - 8
Co-authors Steven Maltby, Rohan Walker, Murielle Kluge
2022 Sanchez-Bezanilla S, Beard DJ, Hood RJ, Aberg ND, Crock P, Walker FR, Nilsson M, Isgaard J, Ong LK, 'Growth Hormone Increases BDNF and mTOR Expression in Specific Brain Regions after Photothrombotic Stroke in Mice', NEURAL PLASTICITY, 2022 (2022) [C1]
DOI 10.1155/2022/9983042
Citations Scopus - 5Web of Science - 3
Co-authors Daniel J Beard, Michael Nilsson, Rohan Walker
2022 Ryan A, Paul CL, Cox M, Whalen O, Bivard A, Attia J, Bladin C, Davis SM, Campbell BC, Parsons M, Grimley RS, Anderson C, Donnan GA, Oldmeadow C, Kuhle S, Walker FR, Hood RJ, Maltby S, Keynes A, Delcourt C, Hatchwell L, Malavera A, Yang Q, Wong A, Muller C, Sabet A, Garcia-Esperon C, Brown H, Spratt N, Kleinig T, Butcher K, Levi CR, 'TACTICS-Trial of Advanced CT Imaging and Combined Education Support for Drip and Ship: evaluating the effectiveness of an 'implementation intervention' in providing better patient access to reperfusion therapies: protocol for a non-randomised controlled stepped wedge cluster trial in acute stroke', BMJ OPEN, 12 (2022)
DOI 10.1136/bmjopen-2021-055461
Citations Scopus - 3Web of Science - 3
Co-authors Carlos Garciaesperon, Chris Paul, Neil Spratt, Christopher Oldmeadow, Rohan Walker, Christopher Levi, Steven Maltby, John Attia, Mark Parsons, Olivia Whalen
2021 Zalewska K, Hood RJ, Pietrogrande G, Sanchez-Bezanilla S, Ong LK, Johnson SJ, Young KM, Nilsson M, Walker FR, 'Corticosterone Administration Alters White Matter Tract Structure and Reduces Gliosis in the Sub-Acute Phase of Experimental Stroke', INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 22 (2021) [C1]

White matter tract (WMT) degeneration has been reported to occur following a stroke, and it is associated with post-stroke functional disturbances. White matter patholo... [more]

White matter tract (WMT) degeneration has been reported to occur following a stroke, and it is associated with post-stroke functional disturbances. White matter pathology has been suggested to be an independent predictor of post-stroke recovery. However, the factors that influence WMT remodeling are poorly understood. Cortisol is a steroid hormone released in response to prolonged stress, and elevated levels of cortisol have been reported to interfere with brain recovery. The objective of this study was to investigate the influence of corticosterone (CORT; the rodent equivalent of cortisol) on WMT structure post-stroke. Photothrombotic stroke (or sham surgery) was induced in 8-week-old male C57BL/6 mice. At 72 h, mice were exposed to standard drinking water ± CORT (100 µg/mL). After two weeks of CORT administration, mice were euthanised and brain tissue collected for histological and biochemical analysis of WMT (particularly the corpus cal-losum and corticospinal tract). CORT administration was associated with increased tissue loss within the ipsilateral hemisphere, and modest and inconsistent WMT reorganization. Further, a structural and molecular analysis of the WMT components suggested that CORT exerted effects over axons and glial cells. Our findings highlight that CORT at stress-like levels can moderately influence the reorganization and microstructure of WMT post-stroke.

DOI 10.3390/ijms22136693
Citations Scopus - 7Web of Science - 5
Co-authors Sarah Johnson, Michael Nilsson, Rohan Walker
2021 Hood RJ, Maltby S, Keynes A, Kluge MG, Nalivaiko E, Ryan A, Cox M, Parsons MW, Paul CL, Garcia-Esperon C, Spratt NJ, Levi CR, Walker FR, 'Development and Pilot Implementation of TACTICS VR: A Virtual Reality-Based Stroke Management Workflow Training Application and Training Framework', FRONTIERS IN NEUROLOGY, 12 (2021) [C1]
DOI 10.3389/fneur.2021.665808
Citations Scopus - 1Web of Science - 10
Co-authors Steven Maltby, Neil Spratt, Rohan Walker, Chris Paul, Christopher Levi, Murielle Kluge, Mark Parsons, Carlos Garciaesperon
2021 Sanchez-Bezanilla S, Hood RJ, Collins-Praino LE, Turner RJ, Walker FR, Nilsson M, Ong LK, 'More than motor impairment: A spatiotemporal analysis of cognitive impairment and associated neuropathological changes following cortical photothrombotic stroke', JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 41, 2439-2455 (2021) [C1]

There is emerging evidence suggesting that a cortical stroke can cause delayed and remote hippocampal dysregulation, leading to cognitive impairment. In this study, we ... [more]

There is emerging evidence suggesting that a cortical stroke can cause delayed and remote hippocampal dysregulation, leading to cognitive impairment. In this study, we aimed to investigate motor and cognitive outcomes after experimental stroke, and their association with secondary neurodegenerative processes. Specifically, we used a photothrombotic stroke model targeting the motor and somatosensory cortices of mice. Motor function was assessed using the cylinder and grid walk tasks. Changes in cognition were assessed using a mouse touchscreen platform. Neuronal loss, gliosis and amyloid-ß accumulation were investigated in the peri-infarct and ipsilateral hippocampal regions at 7, 28 and 84 days post-stroke. Our findings showed persistent impairment in cognitive function post-stroke, whilst there was a modest spontaneous motor recovery over the investigated period of 84 days. In the peri-infarct region, we detected a reduction in neuronal loss and decreased neuroinflammation over time post-stroke, which potentially explains the spontaneous motor recovery. Conversely, we observed persistent neuronal loss together with concomitant increased neuroinflammation and amyloid-ß accumulation in the hippocampus, which likely accounts for the persistent cognitive dysfunction. Our findings indicate that cortical stroke induces secondary neurodegenerative processes in the hippocampus, a region remote from the primary infarct, potentially contributing to the progression of post-stroke cognitive impairment.

DOI 10.1177/0271678X211005877
Citations Scopus - 3Web of Science - 21
Co-authors Rohan Walker, Michael Nilsson
2021 Hair K, Sena ES, Wilson E, Currie G, Macleod M, Bahor Z, Sena C, Ayder C, Liao J, Tanriver Ayder E, Ghanawi J, Tsang A, Collins A, Carstairs A, Antar S, Drax K, Neves K, Ottavi T, Chow YY, Henry D, Selli C, Fofana M, Rudnicki M, Gabriel B, Pearl EJ, Kapoor SS, Baginskaite J, Shevade S, Chung A, Przybylska MA, Henshall DE, Hajdu KL, McCann S, Sutherland C, Lubiana Alves T, Blacow R, Hood RJ, Soliman N, Harris A, Swift SL, Rackoll T, Percie du Sert N, Waldron F, Macleod M, Moulson R, Low JW, Rannikmae K, Miller K, Bannach-Brown A, Kerr F, Hébert HL, Gregory S, Shaw IW, Christides A, Alawady M, Hillary R, Clark A, Jayasuriya N, Sives S, Nazzal A, Jayasuriya N, Sewell M, Bertani R, Fielding H, Drury B, 'Building a Systematic Online Living Evidence Summary of COVID-19 Research', Journal of EAHIL, 17, 21-26 (2021) [C1]
DOI 10.32384/jeahil17465
2021 Zhao Z, Hood RJ, Ong LK, Pietrogrande G, Sanchez Bezanilla S, Warren KE, Ilicic M, Kluge MG, TeBay C, Ottersen OP, Johnson SJ, Nilsson M, Walker FR, 'Exploring How Low Oxygen Post Conditioning Improves Stroke-Induced Cognitive Impairment: A Consideration of Amyloid-Beta Loading and Other Mechanisms', FRONTIERS IN NEUROLOGY, 12 (2021) [C1]
DOI 10.3389/fneur.2021.585189
Citations Scopus - 4Web of Science - 4
Co-authors Rohan Walker, Murielle Kluge, Michael Nilsson, Marina Paul, Sarah Johnson
2021 Bothwell SW, Omileke D, Hood RJ, Pepperall D-G, Azarpeykan S, Patabendige A, Spratt NJ, 'Altered Cerebrospinal Fluid Clearance and Increased Intracranial Pressure in Rats 18 h After Experimental Cortical Ischaemia', FRONTIERS IN MOLECULAR NEUROSCIENCE, 14 (2021) [C1]
DOI 10.3389/fnmol.2021.712779
Citations Scopus - 9Web of Science - 6
Co-authors Neil Spratt
2019 Patabendige A, MacKovski N, Pepperall D, Hood R, Spratt N, 'A26 Cerebrospinal fluid outflow resistance is increased following small-moderate ischaemic stroke (vol 16, 16, 2019)', FLUIDS AND BARRIERS OF THE CNS, 16 (2019)
DOI 10.1186/s12987-019-0144-7
Citations Scopus - 3Web of Science - 4
Co-authors Neil Spratt
2018 Tan KN, Hood R, Warren K, Pepperall D, Carrasco-Pozo C, Manzanero S, Borges K, Spratt NJ, 'Heptanoate is neuroprotective in vitro but triheptanoin post-treatment did not protect against middle cerebral artery occlusion in rats', NEUROSCIENCE LETTERS, 683, 207-214 (2018) [C1]

Triheptanoin, the medium-chain triglyceride of heptanoate, has been shown to be anticonvulsant and neuroprotective in several neurological disorders. In the gastrointes... [more]

Triheptanoin, the medium-chain triglyceride of heptanoate, has been shown to be anticonvulsant and neuroprotective in several neurological disorders. In the gastrointestinal tract, triheptanoin is cleaved to heptanoate, which is then taken up by the blood and most tissues, including liver, heart and brain. Here we evaluated the neuroprotective effects of heptanoate and its effects on mitochondrial oxygen consumption in vitro. We also investigated the neuroprotective effects of triheptanoin compared to long-chain triglycerides when administered after stroke onset in rats. Heptanoate pre-treatment protected cultured neurons against cell death induced by oxygen glucose deprivation and N-methyl-D-aspartate. Incubation of cultured astrocytes with heptanoate for 2 h increased mitochondrial proton leak and also enhanced basal respiration and ATP turnover, suggesting that heptanoate protects against oxidative stress and is used as fuel. However, continuous 72 h infusion of triheptanoin initiated 1 h after middle cerebral artery occlusion in rats did not alter stroke volume at 3 days or neurological deficit at 1 and 3 days relative to long-chain triglyceride control treatment.

DOI 10.1016/j.neulet.2018.07.045
Citations Scopus - 5Web of Science - 4
Co-authors Neil Spratt
2016 Beard DJ, Logan CL, McLeod DD, Hood RJ, Pepperall D, Murtha LA, Spratt NJ, 'Ischemic penumbra as a trigger for intracranial pressure rise - A potential cause for collateral failure and infarct progression?', JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 36, 917-927 (2016) [C1]
DOI 10.1177/0271678X15625578
Citations Scopus - 1Web of Science - 15
Co-authors Neil Spratt, Damian Mcleod, Lucy Murtha, Daniel J Beard
2016 Tomkins AJ, Hood RJ, Pepperall D, Null CL, Levi CR, Spratt NJ, 'Thrombolytic Recanalization of Carotid Arteries Is Highly Dependent on Degree of Stenosis, Despite Sonothrombolysis', JOURNAL OF THE AMERICAN HEART ASSOCIATION, 5 (2016) [C1]
DOI 10.1161/JAHA.115.002716
Citations Scopus - 1Web of Science - 9
Co-authors Neil Spratt, Christopher Levi
2015 McLeod DD, Parsons MW, Hood R, Hiles B, Allen J, McCann SK, Murtha L, Calford MB, Levi CR, Spratt NJ, 'Perfusion computed tomography thresholds defining ischemic penumbra and infarct core: studies in a rat stroke model', INTERNATIONAL JOURNAL OF STROKE, 10, 553-559 (2015) [C1]

Background: Perfusion computed tomography is becoming more widely used as a clinical imaging tool to predict potentially salvageable tissue (ischemic penumbra) after is... [more]

Background: Perfusion computed tomography is becoming more widely used as a clinical imaging tool to predict potentially salvageable tissue (ischemic penumbra) after ischemic stroke and guide reperfusion therapies. Aims: The study aims to determine whether there are important changes in perfusion computed tomography thresholds defining ischemic penumbra and infarct core over time following stroke. Methods: Permanent middle cerebral artery occlusion was performed in adult outbred Wistar rats (n=6) and serial perfusion computed tomography scans were taken every 30 mins for 2h. To define infarction thresholds at 1h and 2h post-stroke, separate groups of rats underwent 1h (n=6) and 2h (n=6) of middle cerebral artery occlusion followed by reperfusion. Infarct volumes were defined by histology at 24h. Co-registration with perfusion computed tomography maps (cerebral blood flow, cerebral blood volume, and mean transit time) permitted pixel-based analysis of thresholds defining infarction, using receiver operating characteristic curves. Results: Relative cerebral blood flow was the perfusion computed tomography parameter that most accurately predicted penumbra (area under the curve=0·698) and also infarct core (area under the curve=0·750). A relative cerebral blood flow threshold of <75% of mean contralateral cerebral blood flow most accurately predicted penumbral tissue at 0·5h (area under the curve=0·660), 1h (area under the curve=0·659), 1·5h (area under the curve=0·636), and 2h (area under the curve=0·664) after stroke onset. A relative cerebral blood flow threshold of <55% of mean contralateral most accurately predicted infarct core at 1h (area under the curve=0·765) and at 2h (area under the curve=0·689) after middle cerebral artery occlusion. Conclusions: The data provide perfusion computed tomography defined relative cerebral blood flow thresholds for infarct core and ischemic penumbra within the first two hours after experimental stroke in rats. These thresholds were shown to be stable to define the volume of infarct core and penumbra within this time window.

DOI 10.1111/ijs.12147
Citations Scopus - 3Web of Science - 1
Co-authors Christopher Levi, Mark Parsons, Lucy Murtha, Damian Mcleod, Neil Spratt
2015 Tomkins AJ, Hood RJ, Levi CR, Spratt NJ, 'Tissue Plasminogen Activator for preclinical stroke research: Neither "rat" nor "human" dose mimics clinical recanalization in a carotid occlusion model', SCIENTIFIC REPORTS, 5 (2015) [C1]
DOI 10.1038/srep16026
Citations Scopus - 1Web of Science - 1
Co-authors Christopher Levi, Neil Spratt
Show 21 more journal articles

Preprint (3 outputs)

Year Citation Altmetrics Link
2025 Freeman-Acquah E, Hood R, Lin C-A, Li Q-X, Gordon L, Martin K, Aryal R, Milward A, Johnstone D, 'A mouse model of hemochromatosis-related mutations with brain iron dyshomeostasis exhibits loss of tyrosine hydroxylase expression in dopaminergic neurons and motor control impairment relevant to Parkinson’s disease' (2025)
DOI 10.1101/2025.05.06.648286
Co-authors Daniel Johnstone
2025 Litman M, Azarpeykan S, Hood R, Martin K, Pepperall D, Omileke D, Uzun O, Bhatta D, Yong Y, Chan A, Hough N, Johnson S, Bermejo PG, Miteff F, Esperon CG, Couch Y, Buchan A, Spratt N, Korin N, Ingber D, Beard D, 'Shear stress targeted delivery of nitroglycerin to brain collaterals improves ischaemic stroke outcome' (2025)
DOI 10.1101/2025.03.25.644833
Co-authors Daniel J Beard
2023 Hood R, Sanchez-Bezanilla S, Beard D, Rust R, Turner R, Stuckey S, Collins-Praino L, Walker F, Nilsson M, Ong LK, 'Leakage beyond the primary infarction: A temporal analysis of cerebrovascular dysregulation at sites of hippocampal secondary neurodegeneration following cortical photothrombotic stroke' (2023)
DOI 10.1101/2023.04.24.538047
Co-authors Daniel J Beard
Edit

Grants and Funding

Summary

Number of grants 4
Total funding $384,430

Click on a grant title below to expand the full details for that specific grant.


20221 grants / $190,000

Stroke Finder: Enhanced Pre-hospital Acute Stroke Triage (EPAST)$190,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Con Prof Chris Levi, Dr Rebecca Hood
Scheme Research Grant
Role Investigator
Funding Start 2022
Funding Finish 2022
GNo G2200739
Type Of Funding C3300 – Aust Philanthropy
Category 3300
UON Y

20201 grants / $169,000

Development, Implementation and Evaluation of State-wide Mixed Reality based training platform for Telestroke$169,000

Funding body: The Agency for Clinical Innovation (ACI) - NSW

Funding body The Agency for Clinical Innovation (ACI) - NSW
Project Team Prof Rohan Walker, Dr Steven Maltby, Dr Rebecca Hood, Dr Murielle Kluge
Scheme Research Grant
Role Investigator
Funding Start 2020
Funding Finish 2021
GNo G2000809
Type Of Funding C2300 – Aust StateTerritoryLocal – Own Purpose
Category 2300
UON Y

20192 grants / $25,430

FHEAM Equipment Grant$24,630

Funding body: Faculty of Health and Medicine, University of Newcastle

Funding body Faculty of Health and Medicine, University of Newcastle
Scheme FHEAM Equipment Grant Round
Role Lead
Funding Start 2019
Funding Finish 2019
GNo
Type Of Funding Internal
Category INTE
UON N

FHEAM Travel Grant$800

Funding body: University of Newcastle - Faculty of Health and Medicine

Funding body University of Newcastle - Faculty of Health and Medicine
Project Team

Rebecca Hood

Scheme Travel Grant
Role Lead
Funding Start 2019
Funding Finish 2019
GNo
Type Of Funding Internal
Category INTE
UON N
Edit

Dr Rebecca Hood

Position

Honorary Associate Lecturer
School of Biomedical Sciences and Pharmacy
College of Health, Medicine and Wellbeing

Contact Details

Email rebecca.hood@newcastle.edu.au
Phone 0883132079
Edit